A transformed view of cyclosporine

Gary J. Nabel

Research output: Contribution to journalArticle

Abstract

Many transplant patients are given the drug cyclosporine to suppress their immune systems and prevent rejection. But cyclosporine also increases the risk of cancer, always thought to be a side effect of the depressed Immune system. A new study shows that cyclosporine directly affects tumour growth and may be the culprit.

Original languageEnglish (US)
Pages (from-to)471-472
Number of pages2
JournalNature
Volume397
Issue number6719
DOIs
Publication statusPublished - Feb 11 1999
Externally publishedYes

    Fingerprint

ASJC Scopus subject areas

  • General

Cite this